The developer of a sensor designed to continuously monitor indoor spaces for pathogens that could cause pandemics has been given a €500,000 prize by Germany’s Merck KGaA i
The World Health Organization (WHO) has said that COVID-19 is no longer a public health emergency of international concern (PHEIC), more than three years after it first de
Merck & Co has said it will ask the EMA’s human medicines committee (CHMP) to look again at a decision not to recommend approval of its antiviral Lagevrio for treating
UK cost-effectiveness agency NICE has published guidance on the use of COVID-19 therapies that can be used for at-risk patients, focusing on three drugs that can be used o
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho